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Abstract
Lagotto Romagnolo breed dogs develop a progressive neurological disease with intracellular vacuolar storage when homozygous
for a variant in the autophagy-related gene 4D (ATG4D). A lysosomal enzyme deficiency has not been proven in this disease,
despite its overlapping morphology with lysosomal storage diseases. Instead, basal autophagy was altered in fibroblasts from
affected dogs. The aim of this study was to clarify the origin of the limiting membrane of the accumulating vacuoles and determine
whether altered basal autophagy affects the extracellular release of vesicles in cells from diseased dogs. When assessed by
immunoelectron microscopy, the membrane of the cytoplasmic vacuoles in affected tissues contained ATG4D, markers for
autolysosomes (microtubule-associated protein 1A/B light chain 3 and lysosome-associated membrane protein 2) and for
recycling endosomes (transferrin receptor 2), indicating that the vacuoles are hybrid organelles between endocytic and autop-
hagic pathways. Ultracentrifugation, nanoparticle tracking analysis, and mass spectrometry were used to analyze the vesicles
released from cultured fibroblasts of affected and control dogs. The amount of extracellular vesicles (EVs) released from affected
fibroblasts was significantly increased during basal conditions in comparison to controls. This difference disappeared during
starvation. The basal EV proteome of affected cells was enriched with cytosolic, endoplasmic reticulum, and mitochondrial
proteins. Heat shock proteins and chaperones, some of which are known substrates of basal autophagy, were identified among the
proteins unique to EVs of affected cells. An increased release of extracellular vesicles may serve as a compensatory mechanism in
disposal of intracellular proteins during dysfunctional basal autophagy in this spontaneous disease.
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Extracellular vesicles (EVs) are a diverse group of
membrane-bound particles released by several cell types into
the surrounding extracellular space. These vesicles have vari-
ous intracellular origins and are produced via several different
mechanisms.12,28 The function and content of EVs has been a
field of intense research since the discovery that EVs can trans-
fer RNA between cells29 and that spread of toxic and/or infec-
tious proteins can be propagated through the release and uptake
of EVs.3,16,27 EVs also function in intercellular signaling and
may contain disease-specific content and potential biomarkers,
as increased EV release is one compensatory disposal mechan-
ism for misfolded or aggregated protein.8,16,27 The classifica-
tion of EVs based on size and release mechanism is not strict,
but continuously evolving. The term EVs comprises both exo-
somes, which are small, <100-nm intraluminal vesicles (ILVs)
released from the endosomal compartment through fusion of
multivesicular bodies with the plasma membrane, and larger
>100-nm microvesicles directly budding from the plasma
membrane.12,28 Larger vesicles, which expose phosphatidylser-
ine and form through apoptosis, are also shed as EVs.12,28 In
addition, it was recently shown that the autophagic pathway
affects EV biogenesis, as EVs may display both autophagoso-
mal and exosomal proteins.12,16 Amphisomes, hybrid
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organelles between the endosomal and the autophagosomal
compartments, also release several nonvesicular nanoparticles
co-isolating with EVs, such as DNA and histones.12
Within the cell, macroautophagy encloses aggregated
protein and damaged organelles from the cytoplasm into a
double-membrane-bound vesicle, the autophagosome, and
shuttles the content to the lysosome for degradation.17,18
A transient organelle, the autolysosome, is formed by fusion
between the autophagosome and the lysosome. The autolyso-
somal content is thereafter released into the cytoplasm as nutri-
ents or as material for biosynthetic reactions, or it is exocytosed
through fusion of the autolysosome with the plasma mem-
brane.17,18 When cells enclose extracellular material into a
cytoplasmic membrane-bound vesicle through endocytosis, the
content enters the endolysosomal pathway, with alternating
endpoints similar to autophagy. The endosomal content can
be delivered back to the plasma membrane and released extra-
cellularly through recycling endosomes or through multivesi-
cular bodies. It can also be digested after fusion with the
lysosome. The autophagic and the endolysosomal pathways
intersect at the level of multivesicular bodies, as autophago-
somes may fuse with multivesicular bodies to form amphi-
somes.10,14 The mechanisms determining and regulating
whether the vesicular content is released extracellularly, or
degraded intracellularly, are largely unknown and may differ
depending on the nutrient conditions of the cell.19,32
Lagotto Romagnolo dogs homozygous for the mutant allele
at a missense variant of the autophagy-related gene ATG4D
(c1288G>A; p. Ala430Thr) develop progressive neurological
decline and a histopathological phenotype characterized by
intracellular accumulation of membrane-bound vacuoles in
various cells.13,26 Cells of affected dogs show altered basal
autophagy, but functional starvation-induced autophagy. Accu-
mulation of single membrane-bound vacuoles in the cell has
long been considered the morphological hallmark of lysosomal
storage diseases, a group of degenerative progressive diseases
caused by defective production, function, or targeting of lyso-
somal degradative enzymes or lysosomal proteins. Several
lysosomal storage diseases affecting dogs have been used in
disease modeling as they share the genetic background and
morphologic phenotype with similar human diseases.
However, it has also been shown that disruption in the
endolysosomal flux19 or in the release of autophagic vacuolar
compartments4 may lead to accumulation of intracellular
membrane-bound vacuoles, despite normal lysosomal function.
So far, the origin of the vacuolar limiting membrane and the
fate of the accumulating vacuoles in affected Lagotto Romag-
nolo dogs are still unknown, as neither a lysosomal defect nor
accumulation of autophagosomes has been linked to the dis-
ease. The aim of this study was to elucidate the origin of the
limiting membrane of the accumulating vacuoles and to test the
hypothesis that the extracellular release of vesicles is altered
during basal autophagy in the affected cells.
Materials and Methods
Ethics Statement
The affected dogs were privately owned pets, undergoing
euthanasia and autopsy at request of the owner, due to progres-
sive neurological signs. The control dogs underwent surgery
for various medical reasons (Table 1) with the owners’ consent.
Sampling was performed according to clinical standards
approved by the Animal Ethics Committee at the State Provin-
cial Office of Southern Finland (Permit: ESAVI/6054/
04.10.03/2012).
Material
Fibroblasts from skin biopsies of 3 clinically affected Lagotto
Romagnolo dogs (cases 1–3), genetically confirmed to be
homozygous for the ATG4Dmut/mut genotype (c.1288G>A;
p.Ala430Thr), were included in the study. One dog underwent
postmortem examination at the University of Bern, Switzerland
(case 3), and 2 dogs at the University of Helsinki, Finland
(cases 1 and 2). Fibroblasts obtained from the ventral skin
incision during routine surgery of 3 clinically healthy Lagotto
Romagnolo dogs (cases 4–6) were used as control material.
Two control dogs were heterozygous (cases 4 and 6) and 1 dog
was wild type (case 5) for the ATG4D variant. Demographic
data of the affected and control dogs included in the study are
presented in Table 1.
Immunoelectron Microscopy
Tissue samples of the dorsal root ganglion (DRG) and pancreas
of one affected dog (case 1) were obtained within 1 hour after
death. Tissues were fixed for 2 hours in 4% paraformaldehyde,
then transferred to 2% paraformaldehyde, until embedded into
Lowicryl K4M for immunoelectron microscopy (IEM).
Briefly, grids with ultrathin tissue sections were blocked with
5% bovine serum albumin (BSA; Sigma-Aldrich), 0.5% fish
skin gelatin (G7765, Sigma-Aldrich CAS 9000-70-8), and 1%
fetal bovine serum (FBS; 10500056 Gibco) in NaPO4 buffer,
pH 7.4.
The grids were then incubated with primary antibodies
against microtubule-associated protein 1A/B light chain 3
(LC3; Abcam ab48394 rabbit polyclonal) as a marker for
Table 1. Demographic Data Regarding the Lagotto Romagnolo Dogs
From Which Dermal Fibroblasts Were Obtained for the Study.
Case Group Sex Age Main clinical finding
1 Affected Female 5 years Hemorrhagic gastroenteritis,
neurological declinea, ataxia
2 Affected Male 5 years Neurological declinea, ataxia
3 Affected Female 7 years Neurological declinea, ataxia
4 Control Female 4 years Ovariohysterectomy
5 Control Female 5 years Mammary tumor
6 Control Male 8 years Skin tumor
aNeurological decline included episodic nystagmus and behavioral changes such
as restlessness, depression, and aggression.
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autophagosomal membranes, transferrin-receptor 2 (TFR2;
ThermoFischer PA5-42732 rabbit polyclonal) as a marker for
endosomal membranes, lysosomal-associated membrane
protein-2 (LAMP2; LSBio 3144 mouse monoclonal) as a mar-
ker for lysosomal membranes, and ATG4D (SAB1301447;
Sigma Aldrich rabbit polyclonal) for 2 hours at room tempera-
ture. For determining nonspecific staining density, control sec-
tions without primary antibody (for LAMP2) or incubated with
a rabbit-isotype control antibody (Rabbit IgG polyclonal iso-
type control Abcam ab37415, for ATG4D, LC3, and TFR)
were included. After washing, a 20-minute incubation with
protein-A-conjugated 10-nm gold or gold-conjugated
goat-anti mouse secondary antibody was performed. Sections
were washed, post-fixed for 5 minutes with 5% glutaraldehyde,
and post-stained with uranyl acetate and lead citrate.
Samples were viewed with a Jeol Jem-1400 (Jeol Ltd)
electron microscope equipped with a Gatan Orius SC1000B
bottom mounted CCD camera (Gatan Inc) at 80 kV. The raw
gold labelling density of membranous and nonmembranous
areas in the cells was quantified using ImageJ software (Fiji,
by Wayne Rasband, National Institute of Mental Health,
Bethesda, MD). A minimum of 50 gold particles, or all particles
in 10 fields of view at 10 000magnification, were recorded as
either membranous or nonmembranous. Gold particles within
15 nm of a membrane were considered membranous. The total
membranous versus nonmembranous area in the pictures were
measured. The specificity of the label was calculated for each
antibody, according to guidelines for quantitative assessment of
specificity in IEM.15 Briefly, the specific labelling density was
counted as the total membranous gold density (dots/mm2) minus
the nonspecific membranous labelling density noted in sections
incubated without a primary antibody or with the isotype con-
trol antibody (ie, D(s)¼D (þ)D ()). For antibodies detect-
ing both a membranous and a cytoplasmic protein (LC3,
ATG4D), the specificity was also assessed using the w2 test
comparing membranous versus nonmembranous gold label dis-
tribution with that of the isotype control.
Analysis of Extracellular Vesicles
Fibroblasts from 3 affected and 3 control Lagotto Romagnolo
dogs were seeded at equal cell density, during second or third
passage, into two 175 cm2 flasks each and cultured for 48 hours
in high-glucose Dulbecco’s modified Eagle medium (DMEM;
41965-039 Gibco) supplemented with 10% fetal bovine serum
(FBS; 10500056 Gibco) and penicillin-streptomycin (PenStrep;
15140122 Gibco). The cells were then washed 3 times with
phosphate-buffered saline (PBS) and the medium changed into
25 ml DMEM supplemented with 10% EV-free fetal bovine
serum (EV core facility, University of Helsinki; FBS centri-
fuged at 110 000g for 18 hours) and penicillin-streptomycin per
flask. Cells were grown into semiconfluency for 72 hours, and
after visual control of cellular integrity, the medium was har-
vested from affected and control cells by decanting into sterile
Falcon tubes.
The cells were washed thrice with PBS and subjected to a
2-hour starvation in Earl’s Balanced Salt Solution (EBSS;
24010043 Gibco). The conditioned EBSS was harvested after
the starvation. The total harvested medium (50 ml) from each
culture was immediately cooled, and centrifuged at 2500g and
þ4 C for 30 minutes. The supernatant with EVs was frozen at
80 C. EVs were enriched through ultracentrifugation at
110 000g for 2 hours. The pellet was resuspended in 1 ml of
Dulbecco’s phosphate-buffered saline (DPBS) buffer and
further ultracentrifuged at 110 000g for 90 minutes. The final
EV pellet was resuspended in 100 ml of (DPBS). For quality
control, one sample from each dog was viewed using negative
staining by transmission electron microscopy. EVs were loaded
on 200 mesh pioloform- and carbon-coated glow-discharged
copper grids. Samples were fixed with 2% PFA (Electron
Microscopy Sciences) in 0.1 M NaPO4 buffer (pH 7.0), stained
with 2% neutral uranyl acetate, embedded in methyl cellulose
uranyl acetate mixture (1.8/0.4%), and viewed with transmis-
sion electron microscopy using Tecnai 12 (FEI Company,
Eindhoven, The Netherlands) operating at 80 kV. Images were
taken with Gatan Orius SC 1000B CCD-camera (Gatan Inc).
The EV concentration and size distribution was determined
by nanoparticle tracking analysis (NTA) with Nanosight model
LM14 (Malvern Panalytical) equipped with blue (404 nm,
70 mW) laser and SCMOS camera. The samples were diluted
in DPBS and five 30-second videos were recorded using cam-
era level 14. The data were analyzed using NTA software 3.0
with the detection threshold 1 and screen gain 5. Comparisons
between the concentration of EVs in media from 3 affected and
3 control fibroblasts in one experiment under basal conditions
(FM ¼ full media) and starvation (ST ¼ starvation) were per-
formed. The mean EV concentration in each sample was deter-
mined as an average of 5 measurements using NTA. The size
distribution of EVs in affected and control samples was
compared using mean percentiles for cutoffs at 100 nm,
150 nm, and 250 nm in diameter. The differences in mean
EV concentration and in mean % of EVs smaller than
100 nm, 150 nm, and 250 nm between affected and control
were tested for statistical significance using the linear mixed
model method for dependent samples. Differences with P < .05
were considered statistically significant.
Extracellular Vesicle Proteomics
The proteomes of EVs harvested from 50 ml media of affected
and control fibroblasts during basal conditions and after 2-hour
starvation were analyzed by mass spectrometry. Briefly, the
whole proteome of EVs in 50 ml medium of equally seeded,
semiconfluent fibroblasts from affected and control Lagotto
Romagnolo dogs was trypsinized into peptides, washed, and
sorted according to hydrophobicity with a C18 liquid chroma-
tography column. The peptides were sorted according to
mass/charge ratio in a mass spectrometer and the 10 most
abundant precursor peaks of the MS1 spectrum selected for
further analysis. The fragmentation spectra were filtered with
an accepted false discovery rate of 5%. Peptides were identified
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based on canine proteins annotated in the Uniprot data base
(https://www.uniprot.org/proteomes/UP000002254) using Pro-
teome Discoverer software (ThermoFisher). Unreviewed
canine proteins and the ATG4D variant c.1288G>A were
included in the search. Proteins identified based on 2 or more
specific peptides and with 2 or more peptide spectrum matches
(PSM) were included in further analysis as outlined in Figure 1.
Proteins present in 2 or 3 samples from affected dogs were
grouped to represent the EV proteome of the affected group,
and proteins present in 2 or 3 samples from controls were
grouped to represent the EV proteome of the control group.
The unique proteins of each group were determined as proteins
present in 2 or all 3 samples of the group but absent in all 3 of
the comparison group. FunRich software for functional enrich-
ment and interaction network analysis of genes and proteins
(http://www.funrich.org/) was used for qualitative analysis as
well as comparison of the cellular compartment of origin and
molecular function of the EV proteins. For
protein-content-based EV characterization and quality control
of the EV proteomes in general, proteins from categories 1, 2,
and 3 (Table 3 in Théry et al28) were used as reference. The
data analyzed in this study are available in Supplemental Mate-
rials (proteomic results) or upon request to the author (IEM
quantification, NTA data).
Results
The Limiting Membranes of Accumulating Vesicles
Contain Lysosomal, Autophagosomal, and Endosomal
Proteins
IEM was used to study the identity of the vacuoles accumu-
lating in the affected tissues (Supplemental Figs. S1 and S2).
The limiting membranes of the vacuoles that accumulated in
the cells of one affected dog were characterized. The gold
labeling density of lysosomal, autophagosomal, and endoso-
mal proteins on the limiting membrane of cytoplasmic
vacuoles in 2 affected organs (pancreas and DRG; Figs. 2, 3)
was compared to the gold labeling density in sections of the
same organs that were incubated with an isotype-control anti-
body and to those incubated without a primary antibody. The
average membranous gold labeling density on the vacuolar
membrane was 0.7 particles/mm2 in preparations without a
primary antibody, and 3.2 particles/mm2 in preparations
labeled with the isotype control antibody. The nonspecific
membranous gold labeling density of 3.2 particles/mm2 was
subtracted from the membranous gold labeling density in
sections labelled with LAMP2, LC3, TFR2, and ATG4D. The
remaining gold label on the vacuolar membranes was inter-
preted as specific. The quantitative assessment of the IEM
gold label specificity, when corrected with the nonspecific
labeling of isotype controls, is presented in Table 2.
IEM readily detected LAMP2 at the limiting membranes
of the vacuoles that accumulate in both DRG neurons and
pancreatic acinar cells (Fig. 4) with several-fold higher spe-
cific membranous labeling density than that of the nonspeci-
fic labeling (Table 2). The vacuolar limiting membrane was
positively labeled for TFR2 and ATG4D in pancreas, with a
weaker positive signal for these markers in the DRG (Figs.
5, 7). LC3 and ATG4D showed the weakest specific mem-
branous labeling density (Table 2, Fig. 6). Both the LC3 and
the ATG4D antibody bind to proteins that can locate on the
autophagosomal membrane and be free in the cytoplasm.
When comparing the labeling distribution (membranous vs
cytoplasmic) of LC3 and of ATG4D with that of the isotype
control antibody by the w2 test, there was a statistically sig-
nificant shift toward pancreatic membranous labeling in both
markers, indicating that LC3 and ATG4D are part of the
limiting membrane of the accumulating vacuoles. In conclu-
sion, the limiting membrane of the vacuoles accumulating in
the affected tissues contain lysosomal, endosomal, and autop-
hagosomal proteins. Furthermore, ATG4D is localized to the
limiting membrane of the accumulating vacuoles in Lagotto
Romagnolo dogs with the ATG4D variant.
Figure 1. Overview of the grouping and workflow regarding the
analysis of the extracellular vesicle (EV) proteomes. The common
EV proteome of controls (Common controls; asterisks in top left
panel) was defined as proteins identified in EVs of 2 or more control
dogs. The common EV proteome of affected cells (Common affected;
asterisks in top right panel) was defined as proteins identified in 2 or
more affected dogs. The Common affected and Common control
proteomes were compared. Proteins unique to control EVs (asterisks
in lower left panel) and unique to affected EVs (asterisks in lower right
panel) were defined as proteins present in the common proteome of
the group but absent in the comparison group.
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Cells With the ATG4D Variant Release Increased
Amounts of EVs Under Basal Conditions
The concentration and size distribution of EVs released from
fibroblasts of affected dogs and control dogs were compared.
During basal conditions, the mean concentration of EVs in the
medium of affected fibroblasts was significantly higher than
that of control fibroblasts (Table 3). During starvation, the
differences disappeared. The size distribution of EVs was not
Figures 2–7. Lagotto Romagnolo dog with variant ATG4D gene. Case 1. Transmission electron microscopy (TEM) and immunoelectron microscopy
(IEM). Figure 2. Pancreas. Acinar cells have numerous cytoplasmic membrane-bound clear vacuoles. TEM. Bar ¼ 5 mm. Figure 3. Dorsal root
ganglion (DRG). A neuron has extensive cytoplasmic vacuolization. IEM; isotype control antibody. Bar¼ 5 mm. Figure 4. Pancreas. Immunolabeling
for LAMP2 protein by gold particles (arrows) on the limiting membranes of the cytoplasmic vacuoles. IEM for LAMP2. Bar¼ 500 nm. Figure 5. DRG.
Gold particles (arrows) represent immunolabeling for ATG4D on the vacuolar limiting membrane. IEM for ATG4D. Bar ¼ 500 nm. Figure 6.
Pancreas. There is lower immuno-gold labeling density for LC3 on the vacuolar membrane (black arrows) and in the cytoplasm (arrowheads). IEM for
LC3. Bar 500 nm. Figure 7. DRG. There is weak labeling for TFR2 on the vacuolar membrane. IEM for TFR2. Bar ¼ 500 nm.
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significantly different when comparing vesicles released from
affected cells to those released by control cells, neither under
basal conditions nor under starvation. Transmission electron
microscopy confirmed the typical cup-shaped form of the
EVs released from affected cells, as well as from control
cells (Fig. 8).
The EV Proteome of Fibroblasts With the ATG4D Variant
Is Enriched With Chaperones During Basal Conditions
Mass spectrometry was used to analyze the proteome of EVs
released from control and affected fibroblasts. During basal
conditions, the proteome of EVs from ATG4D mutant fibro-
blasts was more diverse than that of the control cells, with an
average of 187 + 20 different proteins, compared to an aver-
age of 124 + 34 different proteins in the EV proteome of
control cells (mean + standard deviation). The EV proteomes
of the control cells had 116 different proteins in common
(Fig. 9), while the EV proteomes of affected cells had 159
different proteins in common (Fig. 10). Assessment of the cel-
lular compartment of origin for these proteins revealed a shift
toward those derived from the cytosol, mitochondria, and endo-
plasmic reticulum in the EV proteome of affected cells, with
less proteins derived from the nucleus, lysosomes, and cytos-
keleton than in the control cells (Fig. 11). When comparing the
molecular function of the proteins, the EV proteome of mutant
cells was enriched in proteins with chaperone activity and with
extracellular matrix structural proteins (Fig. 12).
The proteins unique to control or mutant cells were identi-
fied. The unique proteins of the mutant cells included several
chaperone proteins derived from endoplasmic reticulum or
mitochondria (Table 4) as well as membranous and extracel-
lular matrix proteins and proteins with enzymatic activity
(Supplemental Table S1). Also among the unique proteins in
the EVs of mutant cells was the major vault protein involved in
transport, and clathrin heavy chain 1 that is the major protein of
coated pits and vesicles. Among proteins unique to controls,
2 small GTPases active in vesicular transport were detected
(Table 4). P62/sequestosome 1 was present in the EVs of all
3 mutant cases and none of the controls. However, p62 was
detected based on one unique peptide in 2 cases (cases 1 and 2)
and on 3 unique peptides only in case 3 and therefore was not
included in the functional analysis. ATG4D was not detected in
the EV proteomes of affected or control cells.
The majority of proteins in the EV proteome of both
ATG4D mutants (78%) and that of control cells (80%) mapped
to proteins previously shown to locate to exosomes (Fig. 11).
These proteins included transmembrane proteins or proteins
anchored to the plasma membrane and/or endosomes (ie, Cate-
gory 1 in Théry et al28) such as alpha and beta integrins
(ITGA1, ITGA5, ITGB1), heparan sulfate proteoglycans, and
CD44. In addition, a number of cytosolic proteins recovered in
EVs (ie, Category 2 in Théry et al28) were present in the com-
mon proteome of both ATG4D mutant and control cells,
including heat-shock protein family A member 8 (HSPA8),
90 alpha family class B member 1 (HSP90AB1), and annexins
1, 2, 5, and 6 (Supplemental Table S1). As an EV purity assess-
ment, some proteins known to co-isolate with EVs despite
deriving from non-EV structures (ie, Category 3 in Théry
et al28) were used. APOA and APOB were detected in 5/6
samples, and albumin in 6/6 samples. The PSM values for
APOA, APOB, and albumin were comparable between
affected (median 6.2, range 3.6–11.6) and control samples
(median 6.4, range 4.6–9.3). Furthermore, the PSM values
were less abundant than those for annexins and integrins
(affected median 41.1, range 33.2–49; control median 34.8,
range 29.6–40). These results indicate that the EVs isolated
from control and affected cells were equally pure.
Discussion
Here we characterize the limiting membrane of the vacuoles
accumulating in cells of Lagotto Romagnolo dogs with a
mutant ATG4D gene and present the effect of altered basal
autophagy on the amount and proteome of EVs released from
affected cells. The vacuolar membrane contained the lysosomal
marker LAMP2, expressed on late endosomes, conventional
lysosomes, autolysosomes, and secretory lysosomes.5 LC3 was
also detected on the limiting membrane, as was the endosomal
marker TFR2. LC3 is present on autophagosomal membranes
and phagocytic membranes during LC3-assisted phagocyto-
sis.18,22 TFR2 is endocytosed during transferrin uptake and
either recycled back to the plasma membrane through recycling
endosomes or delivered via multivesicular bodies to the lyso-
some for degradation.7 Intracellular accumulation of vacuoles
is a histopathological finding indicative of lysosomal storage
diseases, where the vacuoles have been interpreted as second-
ary lysosomes containing partially or undegraded substrates.
However, recent research has shown that the limiting mem-
brane of the storage compartments can be more diverse, as is
the case in mucopolysaccharidosis IIIB,30 where the mem-
branes derive from the Golgi apparatus, and in multiple sulfa-
tase deficiency and in mucolipidosis type II, where they
represent compartments of the autophagy pathway, namely,
Table 2. Quantitative Assessment of the Specificity of
Immunoelectron Microscopic Gold Labelling on the Limiting
Membrane of the Vesicles That Accumulate in the Pancreas and the
Dorsal Root Ganglion of an Affected Lagotto Romagnolo Dog.
Pancreas Dorsal root ganglion
Antigen D(s)a, gold/mm2 F(s), %b D(s), gold/mm2 F(s), %
LC3I/II 2.8 46* 3.1 46
TRF2 5.1 61 3.0 45
ATG4D 7.3 69* 3.2 47
LAMP2 21.9 95 14.3 93
aD(s): specific membranous labeling density, defined as the total membranous
density subtracted by the unspecific membranous density of isotype and
negative controls.
bF(s): specific labeling fraction, defined as % specific density of total density.
*P < .05 of w2 when comparing membranous versus nonmembranous label
distribution to the label distribution of the isotype control antibody.
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autophagosomes and autolysosomes.6,23 The ATG4D-linked
phenotype in Lagotto Romagnolo dogs adds to this group, as
the main histopathological finding is accumulating intracellular
vacuoles that are not solely of lysosomal origin. Despite a
marker profile indicating that the vacuoles are hybrids between
the endolysosomal and autophagosomal pathways, the mor-
phology is inconsistent with that described for multivesicular
bodies or amphisomes, as the vacuoles do not consistently
contain intraluminal vesicles (ILVs) or sequestered degrading
material.9
When assessed by IEM, ATG4D was detected on the mem-
branes limiting the accumulating vacuoles with a labeling spe-
cificity and density comparable to the known membranous
marker protein TFR2, and the autophagosome marker LC3.
The subcellular location of ATG4D has not been reported, but
functional studies on ATG4 in yeast20 and the human ATG4
paralogues A-D1,11 describe these cysteine proteases as transi-
ently active on the autolysosomal membrane: first, revealing
glycine on LC3 before lipidation, and second, during delipida-
tion and release of LC3I from membrane-bound LC3II. The
main role of ATG4D may not be in degradative, induced autop-
hagy, as it is not required for this process.11 Instead, functional
ATG4D has been linked to extracellular release of autophagic
compartments4 and to caspase activation.24 Recently, it was
shown in yeast that phospholipids on the autophagosomal
membrane are not the sole target for ATG4-mediated LC3
conjugation, as ATG3 was described as an alternate target.1
Interestingly, ATG4 assists in conjugation of LC3 to ATG3
at the same site, which ATG12 uses in the ATG3-ATG12 com-
plex. Notably, the ATG3-ATG12 complex is required for basal
autophagy.19 This provides a potential link between ATG4 and
functional basal autophagy at a molecular level, as altered
ATG4D activity could influence ATG3-ATG12 formation
and therefore affect basal autophagy.1,19
The quantitative and qualitative aspects of EVs and their
content are increasingly being investigated also in veterinary
medicine, especially within the field of companion animal
medicine and veterinary oncology.2,21 Since EV isolation and
characterization is very sensitive to the used methodology,
constant efforts to standardize these aspects are made.28 Dif-
ferential ultracentrifugation with wash is classified as a method
of intermediate EV recovery and intermediate EV specificity28
and was applied in the current study as both quantitative and
qualitative aspects of EVs release from LR fibroblasts were to
be analyzed. It is possible that another EV isolation method
could have revealed additional differences in the EVs released
from fibroblasts of affected Lagotto Romagnolo dogs in com-
parison to those released from control cells. The EV concen-
tration in media from LR control fibroblasts was, however,
similar to the EV concentration previously reported in the cul-
ture medium of canine fibroblasts2 isolated by a different
method, indicating that the chosen isolation method did not
severely affect the quantitative EV aspects. The comparison
of the EV proteome of fibroblasts from affected Lagotto
Romagnolo dogs to breed-matched control cells, undergoing
the same methodology as the affected cells, validate the quali-
tative differences. The EVs released by LR fibroblasts were
overall larger than previously described canine fibroblast EVs;
however, the results are based on only few dogs. In cells with
mutant ATG4D, significantly more EVs were released during
basal conditions in comparison to the controls. Increased release
of EVs has been implicated as an alternate disposal mechanism
and compensatory re-routing of undegraded material in cells
with inhibited autophagosomal-lysosomal degradation,8,31
including rodent and human neuronal cells.16 It is possible that
the accumulating vacuoles in affected cells are late
Table 3. Concentration and Size Distribution of EVs Derived From Culture Medium of Fibroblasts From Affected and Control Lagotto
Romagnolo Dogs.
Exosome concentration (E10/ml)a; mean + SEM Particle size (nm); mean + SEM
Group Full medium Starvation Full medium Starvation
Affected n ¼ 3 9.0 + 0.76* 2.9 + 0.48 203.4 + 5.9 168.8 + 7.9
Controls n ¼ 3 6.7 + 0.76 1.5 + 0.48 195.5 + 8.2 160.6 + 6.5
*P < .05 when compared to control in linear mixed model.
aE10/ml ¼ 1010 particles/ml.
Figure 8. Extracellular vesicles in the culture medium of fibroblasts,
Lagotto Romagnolo dog with variant ATG4D gene, case 3. The
extracellular vesicles show the characteristic single membrane lining
and cupped shape. Transmission electron microscopy, negative stain-
ing. Bar ¼ 500 nm. Inset: Extracellular vesicles in the culture medium
of fibroblasts from a control dog, case 4. Transmission electron
microscopy. Negative staining. Bar 500 nm.
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autophagosomal or endosomal compartments, devoid of content
and ILVs due to extracellular release of the same. Findings in
fibroblasts cannot, however, directly be extrapolated to other
cell types, and it remains to be investigated if the increased
EV release and the enrichment of substrates of basal autophagy
in EVs can be detected also in the serum or plasma of affected
Lagotto Romagnolo dogs. The size spectrum of EVs in mutant
cells did not differ significantly from that of control cells; hence,
the ATG4D-variant does not affect the overall EV profile. Sev-
eral chaperones, such as calreticulin, heat shock protein family
A, and T-complex protein 1 subunits/CCTs, were exclusively
present in the EV proteome of affected cells. Interestingly,
Zhang and colleagues32 modelled dysfunctional basal autop-
hagy in human fibroblasts and detected that the proteasome and
Figures 9–12. Quantitative and qualitative comparison of the extracellular vesicle (EV) proteomes of fibroblasts derived from 3 control and
3 affected Lagotto Romagnolo dogs. Figure 9. Proteomes of the EVs of control cells. Figure 10. Proteomes of the EVs of affected cells. Figure
11. Comparison of the predicted cellular origin of the proteins in EVs from control and affected cells. Figure 12. Comparison of predicted
molecular functions of proteins in the EVs of control and affected cells.
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T-complex protein 1 subunits/CCTs are substrates of basal
autophagy. P62, which was present in the EV proteome of all
affected cells and none of the controls, is a known substrate of
autophagy.32 Our findings indicate that dysfunctional basal
autophagy in cells with mutant ATG4D can redirect basal autop-
hagy substrates into EVs. The small GTPases Ras-related pro-
teins Rab1A and Rab5C were detected among the unique
proteins of the control EV proteome, thus lacking in the EV
proteome of affected cells. As the release of EVs is increased
and the overall EV size profile not significantly different in
affected cells, the lack of GTPases within the EVs may indicate
that the cells with the mutant ATG4D retain the GTPases intra-
cellularly. Rab GTPases are central regulators of membrane
traffic within the autophagic, endosomal-lysosomal, and phago-
somal pathways, with Rab1A and Rab5C mainly locating to the
early endosomal compartment.25 Considering the cytoplasmic
vacuolar tethering, fusion, engulfment, and inverted budding
described in cells and tissues of Lagotto Romagnolo dogs
affected by the vacuolar storage disease,26 the RAB proteins
may be occupied in intracellular membrane traffic in cells with
the ATG4D-mutation.
In conclusion, the limiting membrane of the vacuoles accu-
mulating in the cells of diseased Lagotto Romagnolo dogs with
mutant ATG4D contain proteins of the autophagosomal, endo-
somal, and lysosomal compartments, suggesting they may be
hybrid organelles of these compartments. Fibroblasts from
affected dogs release increased amounts of EVs during basal
conditions and the accumulating vacuoles may contribute to
this in a similar way as amphisomes or multivesicular bodies
contribute to the EV release by fusing with the plasma mem-
brane. During basal conditions, ATG4D mutant cells release
EVs enriched with chaperones, some of which have been
shown to be substrates of basal autophagy.
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Supplemental Figure S1: Pancreas of an af-
fected dog, showing diffuse, variably sized cy-
toplasmic vacuolization of the acinar cells of the 
exocrine pancreas. HE.
Supplemental Figure S2: Neurons in the dorsal 
root ganglium of an affected LR, with cytoplasm 
extended by fine vesicles and occasional larger 
vacuoles. HE.
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COL12A1; COL1A1; COL1A2; EDIL3; FBLN1; FN1; 
THBS1; THBS2; VCAN; Structural constituent of cytoskeleton ACTB; ACTC1; KRT14; Chaperone activity CALR; CANX; CCT3; CCT4; CCT5; HSPA5; PPIB; TCP1; 
Structural constituent of cytoskeleton
ACTN4; CTNNA1; EPB41L2; GSN; MSN; TUBA1A; 
TUBB; VIM; Channel regulator activity STOM; Extracellular matrix structural constituent
COL3A1; COL5A1; COL5A2; LAMA2; LAMB1; LAMB2; 
LAMC1; NID1; 
Cytoskeletal protein binding ACTN1; CALD1; CFL1; FLNC; TLN1; VASP; VCL; GTPase activity RAB1A; RAB5C; Structural constituent of cytoskeleton ACTR1A; ACTR3; TUBB6; 
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Translation regulator activity EEF2; Molecular function unknown ARHGDIA; CYFIP1; 
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Protein binding AHNAK; 
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